MET and neoplasm: The full QSP model is comprised of a cell signaling module and multiple drug pharmacokinetics (PK) modules to systematically describe the mechanisms by which MET pathway dysregulation promotes tumor growth and how targeted pathway interventions inhibit tumor growth (Figure 1).